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Dorfman^Chanarin syndrome is a rare autosomal re-
cessive inherited lipid storage disease characterized by
ichthyosis, leukocyte lipid vacuoles, and involvement
of several internal organs. Recently, CGI-58 mutations
were identi¢ed as the cause of Dorfman^Chanarin syn-
drome. The physiologic roles of the CGI-58 protein and
the pathomechanisms of Dorfman^Chanarin syndrome
still remain to be clari¢ed, however.The patient, a 16-y-
old male, demonstrated ichthyosis, small ears, lipid va-
cuoles in his leukocytes, liver dysfunction, and mental
retardation. Sequencing of CGI-58 revealed that the pa-
tient was homozygous for a novel nonsense mutation
R184X, in exon 4. The putative truncated protein was
52.4% of the length of the normal CGI-58 polypeptide
and lacked approximately 60% of the lipid binding re-
gion, 66.4% of the a/b hydrolase folding segment of the
polypeptide, and two of the CGI-58 catalytic triads, re-
sulting in a signi¢cant loss of lipase/esterase/thioesterase
activity. Electron microscopy revealed a large number
of abnormal lamellar granules, a disturbed intercellular
lamellar structure, and lipid vacuoles in the epidermis.
These results suggested that CGI-58 protein is involved
in the lipid metabolism of lamellar granules and that
defective lipid production in lamellar granules caused
by a CGI-58 protein de¢ciency is involved in the patho-
genesis of ichthyosis in Dorfman^Chanarin syndrome.
Key words: esterase/ichthyosis/lamellar body/lipase/neutral
lipid storage disease. J Invest Dermatol 121:1029 ^1034, 2003
D
orfman^Chanarin syndrome (DCS) (MIM
275630), also referred to as neutral lipid storage dis-
ease with ichthyosis, is a rare autosomal recessively
inherited lipid storage disease (Dorfman et al, 1974;
Chanarin et al, 1975). This entity is characterized by
nonbullous congenital ichthyosiform erythroderma (NBCIE),
leukocyte lipid vacuoles, and by the involvement of several inter-
nal organs. All cases present with skin manifestations of moderate
to severe NBCIE (Williams and Lynch, 1996; Gri⁄ths et al, 1998;
Pena-Penabad et al, 2001). Extracutaneous manifestations variably
include fatty liver, myopathy, cataracts, and a variety of neurolo-
gic symptoms.
Amounts of triacylglycerol in lymphocytes, macrophages, and
¢broblasts cultured from patients were remarkably larger than
those of normal controls (Williams et al, 1988; Hilaire et al, 1995).
Activities of various enzymes for lipid metabolism, including li-
pase and esterase, have been studied and found to be normal
(Williams et al, 1988; Hilaire et al, 1995; Igal and Coleman, 1996;
1998).Thus, the causative defects in lipid metabolism are expected
to involve triacylglycerol metabolism (Williams et al, 1991), espe-
cially in the catabolism of long-chain fatty acids (Hilaire et al,
1994; 1995) or in the recycling pathway of triglycerol-derived
monoacylglycerols or diacylglycerols into phospholipids (Igal
and Coleman, 1996; 1998)
In 2001, CGI-58 mutations were identi¢ed in DCS families
from the Mediterranean region (Lefe' vre et al, 2001), although no
following report of CGI-58 mutations in DCS has been pub-
lished. The physiologic roles of the protein coded by CGI-58 in
various tissues including the epidermis have not yet been clari¢ed
(Lai et al, 2000), and the pathomechanisms of NBCIE caused by
CGI-58 mutations remain unsolved.
In this study, in order to elucidate whether CGI-58 mutations
lead to abnormal granules, epidermal lamellar granules were stu-
died ultrastructurally in a typical DCS patient carrying a novel
homozygous CGI-58 mutation R184X. In addition, to clarify
whether CGI-58 mutations cause other abnormalities in keratini-
zation, ultrastructural observation and immuno£uorescent stain-
ing of other keratinization-associated molecules and in situ
transglutaminase (TGase) activity assays were performed on epi-
dermal samples from the patient with defective CGI-58. Institu-
tional approval was obtained for all work performed in this study,
along with adherence to the Helsinki Principles. Informed guar-
dian’s consent was provided regarding our work with patient’s tis-
sue and cells.
MATERIALS ANDMETHODS
Mutation detection The strategy for mutation detection was as
previously reported (Lefe' vre et al, 2001). Brie£y, genomic DNA isolated
from peripheral blood was subjected to PCR ampli¢cation, followed
by direct automated sequencing. Oligonucleotide primers used for
ampli¢cation of all exons 1^7 of CGI-58 are shown in Table I. These
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primer sequences were derived from the report by Lefe' vre et al (2001) and
were partially modi¢ed according to the subsequently reported mRNA
sequence (Genbank Accession No. AL606839) for this study. Detailed
PCR conditions were previously described (Lefe' vre et al, 2001).
Morphologic observations Skin biopsy samples were ¢xed in one-half
strength Karnovsky’s ¢xative or 2% glutaraldehyde solution, post¢xed in
1% OsO4, dehydrated, and embedded in Epon 812 (Perry et al, 1987). A
peripheral blood sample from the patient was centrifuged and blood cell
pellets were obtained. The cell pellets were ¢xed in glutaraldehyde,
OsO4, and embedded in epoxy resin. The samples were sectioned at 1 mm
thick for light microscopy and thin sectioned for electron microscopy (70
nm thick). The histologic sections were stained by the method of
Richardson et al (1960). The thin sections were stained with uranyl acetate
and lead citrate (Reynolds, 1963) and examined in a transmission electron
microscope.
Antibodies The primary antibodies to keratinization-associated proteins
used in this study were mouse monoclonal antikeratin 1 antibody, 34bB4
(Novocastra Laboratory, Newcastle upon Tyne, UK), mouse monoclonal
antikeratin 10 antibody, DE-K10 (Dako, Glostrup, Denmark), rabbit
polyclonal antihuman involucrin antibody (Biomedical Technologies,
Stoughton, MA), and rabbit polyclonal antimouse loricrin antibody,
which cross-reacts with human loricrin (Berkeley Antibody, Richmond,
CA). Goat polyclonal antibody against human recombinant TGase 1
(major variant) (Kim et al, 1992), whose epitope(s) is located in the central
core of TGase 1 (Kim et al, 1995), was also used.
Immuno£uorescent labeling Immuno£uorescent labeling was per-
formed as described previously (Akiyama et al, 1998a). Brie£y, sections
of fresh patient’s skin 6 mm thick were cut using a cryostat. The sections
were incubated in primary antibody solution for 1 h at 371C. Antibody
dilutions were as follows: 1:1 for anti-involucrin, 1:20 for antikeratin 1
antibody, 1:100 for antikeratin 10 antibody, 1:50 for antiloricrin antibody,
and 1:10 for anti-TGase 1 antibody. The sections were then incubated in
£uorescein isothiocyanate conjugated to rabbit antimouse immuno-
globulins, goat antirabbit immunoglobulins, or rabbit antigoat immuno-
globulins diluted 1:100 (Dako) for 30 min at room temperature, followed
by 10 mg per ml propidium iodide (Sigma Chemical, St Louis, MO) to
counterstain nuclei for 10 s. The sections were extensively washed with
phosphate-bu¡ered saline (PBS) between incubations. The stained sections
were then mounted with a cover slip in 50% glycerol mounting medium
and observed by conventional epi£uorescence microscope or using a
confocal laser scanning microscope.
In situ TGase activity assay In order to study the enzyme activity
of TGase in the skin specimens, an in situ TGase activity assay was
performed as follows. Frozen sections were incubated in 100 mM
TrisHCl pH 7.4, 1% normal mouse serum for 30 min to block
nonspeci¢c binding, and then in 100 mM TrisHCl pH 7.4, 5 mM
CaCl2, 12 mM monodansylcadaverine (Sigma Chemical, St Louis, MO)
for 1 h to detect TGase activity (Hohl et al, 1998; Raghunath et al, 1998;
Akiyama et al, 2001). At PH 7.4 bu¡er conditions for the detection of
TGase 1 activity, but not TGase 3 activity were selected. (Raghunath et al,
1998; Akiyama et al, 2001). For a negative control, ethylenediaminetetraacetic
acid (EDTA) was added to the monodansylcadaverine solution to a ¢nal
concentration of 20 mM. After stopping the TGase reaction with 10 mM
EDTA in PBS, sections were incubated with rabbit antidansyl antibody
(1:100) (Molecular Probes, Eugene, OR) in 12% bovine serum albumin
(BSA)/PBS for 3 h. Sections were then incubated with £uorescein
isothiocyanate (FITC) labeled mouse antirabbit antibody (1:40) in 12%
BSA/PBS for 30 min. Nuclei were counterstained by incubating the
sections in 10 mg per ml propidium iodide (Sigma Chemical) for 10 s.
Localization of TGase activity was observed under a £uorescence
microscope.
RESULTS
Clinical presentation and routine morphologic observa-
tions The patient was a 16-y-old Japanese male. He was the
third child of nonconsanguineous healthy parents. There was no
family history of congenital ichthyosis or abnormal lipid
metabolism. He has two una¡ected elder brothers. The patient
had presented with severe ichthyosis since birth. Physical
examination of the patient at 16 y of age revealed ¢ne, gray, or
light-brownish scales over the entire body surface including the
face, palms, and the soles (Fig 1). The skin was slight-
ly erythrodermic over his entire body surface. The patient’s skin
manifestation was categorized as NBCIE (Akiyama et al,
2003). His auricles were abnormally small (Fig 1a) although
hair, teeth, and nails appeared normal. He had demonstrated
Table I. Primer sequences for CGI-58
Sequence (50 -30)
Forward Reverse
Exon 1 GGCCGTGCTAGTGCGCGGAAGACGCATGCG GGTGGCTTATACAACAACGGGGCGGACCCTCC
Exon 2 CCATGCTTTGTGCATGTTAG AAACAAATCTCCTTGGGGTC
Exon 3 TGAGGTAGGTCTTCCCCTTT AGAGAATGTCTGCCTTGTGG
Exon 4 CGTGAAGGTTTTTGAAGGTG GGGTTCAGGGTTTTCTTGTT
Exon 5 AATGTGTGCTTTTTCCCACC GACCTGGGGTCAGAAGTTCA
Exon 6 CTTAGGTGCTGGAAAAGCTA GTAGTTCACGGTTTGGACAT
Exon 7 TTTAAATACAGTGGCTCTCACTT TCAGAAATCACTTCCTAAATTGG
Figure1. The patient showed a typical clinical phenotype of DCS.
The auricle was small and malformed (a). Fine, light-gray to gray scales
were seen on the £exor aspect (b) and extensor aspect (c) of erythrodermic
skin of the patient’s lower leg and back (d). Scales were seen on the dorsa of
the feet although the nails were normal (e).
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liver dysfunction from infancy and a liver biopsy showed
cirrhosis with severe fatty degeneration. He also had slight
mental retardation, although myopathy, cataracts, hearing loss,
or neurologic symptoms were not seen. Steroid sulfatase activity
in the peripheral blood sample was normal. Light microscopy of
the lesional skin sample from the patient’s trunk showed marked
hyperkeratosis with only a small number of parakeratotic cells
(Fig 2a). There were large cytoplasmic vacuoles containing
amorphous material in the basal cells and the lowermost spinous
cells (Fig 2b). The large vacuoles were similar to those in the
white blood cells and were presumably lipid vacuoles. In the
white blood cells in the peripheral blood, large cytoplasmic lipid
vacuoles characteristic of DCS were observed (data not shown).
CGI-58 mutation analysis Direct sequencing of the patient’s
PCR products revealed that the patient was a homozygote for a
novel nonsense mutation 550C-T transition in exon 4
(sequence according to Lefe' vre et al, 2001) (GenBank Accession
No. AL606839) that changed an arginine residue to a stop codon
(R184X). This mutation was not found in 50 normal unrela-
ted Japanese alleles (25 normal unrelated Japanese individuals)
by sequence analysis, and was unlikely to be a polymorphism
(data not shown). Direct sequencing of all seven exons and
exonintron borders of CGI-58 failed to detect any other
pathogenic mutation in the patient’s DNA. One polymorphism
in exon 7 (amino acid 363, arginine-isoleucine) was found in
the patient’s DNA and some control DNA samples.
Ultrastructure of the upper epidermis in the ichthyotic skin
lesion In the upper spinous and granular layer cells, small lipid
droplets were seen in the cytoplasm and abnormal lamellar
granules were observed (Figs 2c, 3). The features that abnormal
lamellar granules were assembled and forming lipid droplets in
Figure 2. Lipid vacuoles characteristic of DCS were observed in the
basal layer of the patient’s epidermis. (a) A light microscopic view of a
semithin section of the patient’s hyperkeratotic skin showed lipid droplets
(arrows) mainly in the basal layer. (b) Electron microscopy revealed large
intracellular lipid vacuoles (arrowheads) within basal keratinocytes. Arrows,
basement membrane. (c) In the lower corni¢ed layers, intracytoplasmic va-
cuoles (arrows) and electron-lucent intercellular clefts () were seen. (d) An
intact corni¢ed cell envelope (arrowheads) was formed at the periphery of
the corni¢ed layer cells. Bars: (a) 50 mm; (b) 5 mm; (c), (d), 2 mm.
Figure 3. A large number of abnormal lamellar granules in kerati-
nizing cells of the patient’s epidermis. (a) Numerous, large, and irregu-
larly shaped abnormal lamellar granules (arrowheads) lacking the normal
lamellar structure were seen at the periphery of granular cells and some of
them had been secreted into the intercellular space. A disturbed intercellu-
lar lamellar structure was also seen between the granular and corni¢ed cells
(arrows). (b) Abundant abnormal lamellar granules (arrowheads), irregular in
size and shape, were apparent in the upper spinous cell layers. (c) Abnormal
lamellar granules had accumulated and formed an intermediate structure
(arrow) between abnormal lamellar granules and a lipid vacuole. Bars: 1 mm.
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the cytoplasmwere seen in the upper spinous and granular layers.
Intercellular lipid lamellae were disturbed between the granular
cells and the corni¢ed cells. Lipid droplets were also found in
the corni¢ed cells. The corni¢ed cell envelope was normally
formed at the cell periphery of the corni¢ed layer cells (Fig 2d).
In some ¢broblasts and nerve cells in the dermis, abnormal
cytoplasmic lipid inclusions were seen (data not shown).
Immuno£uorescent labeling of keratinization-associated
proteins Immuno£uorescence studies revealed normal expres-
sion of keratin 1 and keratin 10 in the suprabasal layers of the
patient’s hyperkeratotic epidermis (data not shown). Normal
membranous involucrin staining was observed in the upper
spinous and granular layer cells (data not shown). Normal
distribution of loricrin in the uppermost spinous and the
granular layers was also seen in the patient’s epidermis (data not
shown). These staining patterns were similar to those in normal
control skin. Immuno£uorescence demonstrated a normal expres-
sion of theTGase 1molecule mainly in the upper spinous and the
granular layer of the patient’s epidermis (data not shown).
In situTGase activity assay From the middle to upper spinous
layers, normal membrane localized TGase 1 activity was detected
(Fig 4a). In the upper spinous and the granular layers, the
membrane-associated activity became reduced and an abnormal
cytoplasmic granular distribution of TGase 1 activity was seen.
DISCUSSION
Based on the data from clinical, ultrastructural, immunohistolo-
gic, and enzyme-histologic studies, this patient should be diag-
nosed as a typical DCS. The mutation analysis revealed that the
patient was a homozygote for a novel nonsense mutation,
R184X, in exon 4 of CGI-58.
CGI-58 is one of the genes recently identi¢ed using the com-
parative proteomic approach between Caenorhabditis elegans and
human (Lai et al, 2000). CGI was named after comparative gene
identi¢cation. Neither the tissue expression pro¢le nor the phy-
siologic roles of CGI-58 have been clari¢ed yet. CGI-58 belongs
to a large family of proteins characterized by an a/b-fold domain
(Ollis et al, 1992; Heikinheimo et al, 1999) and a catalytic triad
composed of a nucleophile, an acid, and histidine (Zhang et al,
1998; Nardini and Dijkstra, 1999). From the analysis of the re-
ported amino acid sequences, CGI-58 has a putative catalytic triad
as do other members of the esterase/lipase/thioesterase subfamily
(Lefe' vre et al, 2001). The ¢rst element of the triad is a motif close
to a lipase consensus sequence, included in amino acid residues
149^156 (Lefe' vre et al, 2001). The third element of the triad is
around the histidine at residue 327 in the conserved motif, be-
tween amino acid residues 324 and 328. The putative second ele-
ment of the triad could be either the aspartate residue at 301,
inside the motif GARSCIDG (amino acid residues 295^302),
or the glutamic acid residue at 260, inside the motif PSGETA
(amino acid residues 257^262) (Cygler et al, 1993; Schrag and
Cygler, 1997; Lefe' vre et al, 2001). From these facts, CGI-58 is
postulated to be a member of the esterase/lipase/thioesterase
subfamily of proteins.
According to the CGI-58 protein modeling, based on the re-
ported amino acids sequence (Lefe' vre et al, 2001), the novel muta-
tion R184X in this patient leads to a premature termination
codon in the central portion of the CGI-58 polypeptide (Fig 5).
This mutation eliminates approximately 60% of the lipid bind-
ing region and 66% of the a/b hydrolase fold of the polypeptide.
The putative truncated protein from the mutated allele is 52.4%
of the length of the normal CGI-58 polypeptide and lacks two of
the catalytic triads that make CGI-58 a member of the lipase/es-
terase/thioesterase subfamily. This results in a signi¢cant loss of
lipase/esterase/thioesterase activity, and consequently CGI-58 ac-
tivity was predicted to be seriously impaired or completely lost
in this case.
The pathomechanisms of the CGI-58 mutations causing the
multiorgan symptoms in DCS including ichthyosis remain to be
clari¢ed, and the physiologic function of the CGI-58 protein is
still unknown. In the case reported here, in the upper spinous
and granular layers a large number of abnormal lamellar granules
were seen. Some lamellar granules were secreted into the intercel-
lular space between the granular and corni¢ed cells, but the con-
tent secreted from the abnormal lamellar granules formed a
disturbed intercellular lamellar structure and intercellular clefts.
Other abnormal lamellar granules remained in the cytoplasm
Figure 4. Disturbed distribution of in situ TGase 1 activity in the
patient’s epidermis. An in situ TGase activity assay under pH 7.4 bu¡er
conditions showed granular and vacuolated TGase activity in the patient’s
upper spinous and granular layers (a). In control epidermis, membranous
TGase activity is seen in the granular layers (b). (a) The patient’s skin; (b)
control normal human skin. In situTGase activity was labeled using FITC
(green). Nuclear staining was done with propidium iodide (red). Bar: 50 mm.
Figure 5. Schematic sequential arrangement of the
domain structures of CGI-58 protein. Mutations in
the DCS patient are marked by an ascending arrow. Note that
the mutation is just at the N-terminal side (left) of the mid-
dle portion of the molecule. The genetic defect causes a
premature termination codon at the mutation site, result-
ing in the deletion of more than half of the amino acid
sequence of the protein including the second and third ele-
ments of the catalytic triad.
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and developed an intermediate structure midway between lamel-
lar granules and lipid vacuoles. Similarly structured granules
resembling both lipid vacuoles and lamellar granules have
previously been reported in di¡erent neurocutaneous syndromes
associated with ichthyosis and abnormal lipid metabolism
(Koone et al, 1990). Finally, these intermediate structured granules
underwent transformation into lipid vacuoles within the granular
cells and corni¢ed cells. These observations suggested that
a defective synthesis of lipid in lamellar granules caused by
a CGI-58 protein de¢ciency is involved in the pathogenesis of
ichthyosis in DCS.
Formation of a normal epidermal permeability barrier and
normal desquamation require the secretion of lamellar granule
contents into the intercellular spaces between the granular and
corni¢ed cells. Lamellar granules contain both polar lipids and a
family of hydrolytic enzymes that catalyze the extracellular pro-
cessing of the secreted polar lipids into more hydrophobic reac-
tion products (Rassner et al, 1999). Abnormal lamellar granules
and an abnormal secretion of lamellar granule contents were
reported as the likely pathomechanisms for other congenital
ichthyoses including harlequin ichthyosis and NBCIE (Milner
et al, 1992; Akiyama, 1999; Fartasch et al, 1999). In addition, de-
creased quantities of secreted lamellar granule contents in the
intercellular space were linked to abnormal barrier function in
epidermolytic hyperkeratosis (Schmuth et al, 2001). Elias and
Williams (1985) also reported an abnormality in the lipid contents
of lamellar granules in multiple DCS cases from a single family,
although underlying mutations from that family had not been
detected.
In harlequin ichthyosis, lamellar granules are absent or, if
present, they show an empty or vesiculated content without any
lamellar structure. These abnormal lamellar granules are not
secreted to the intercellular space and they form a large number
of lipid droplets within the corni¢ed cells (Dale et al, 1990;
Hashimoto and Khan, 1992; Milner et al, 1992; Akiyama et al,
1994,1998b). In contrast, the case with DCS reported here showed
that most of the lamellar granules do have a lamellar structure
although they are incompletely formed and some granules are se-
creted to the intercellular space. These ¢ndings suggest that har-
lequin ichthyosis has a di¡erent pathomechanism from the
defective CGI-58 protein, although both DCS and harlequin
ichthyosis do show abnormal lamellar granules.
After the ¢rst report by Lefe' vre et al (2001), no subsequent
CGI-58 mutations in DCS have appeared. Thus, we cannot com-
pletely exclude the possibility that the cause of DCS may be het-
erogeneous, especially in patients from outside the Mediterranean
region. The case reported is important because the DCS patient is
from a non-Mediterranean region but still harbors CGI-58 muta-
tion defects.
In the report of Lefe' vre et al (2001), eight CGI-58 mutations
were found as the causative mutations out of 13 DCS patients
from nine families. All the patients were homozygous for their
CGI-58 mutations and the CGI-58 mutations were thought to
cause a partial or total loss of CGI-58 activity and lead to various
clinical features belonging to DCS (Lefe' vre et al, 2001). In the
patients carrying the milder, missense mutations, no poorly
formed ears were observed and, morphologically, no lipid
droplets were seen in the basal layer keratinocytes. In contrast,
not all, but most, of the patients with nonsense mutations that
might result in the production of truncated proteins that lack
the entire lipid binding domain or more than half of the lipid
binding domain including two elements of the catalytic triad
showed small ears and abnormal lipid vacuoles in the basal cells
of the epidermis. The mutation R184X also causes a truncated
CGI-58 protein and the patient showed small ears and a large
number of lipid vacuoles in the basal and lowermost spinous
layers of the epidermis. These facts support the hypothesis that
a serious loss of CGI-58 activity may lead to small ears and the
presence of lipid droplets in the basal epidermal layer.
In this case, large cytoplasmic vacuoles characteristic of DCS
were observed in the basal and lowermost spinous layers and the
vacuoles gradually became obscured in the upper layers. Consid-
ering that the most important site for the pathogenesis of corni-
¢cation disorders is not the basal layer but the upper spinous and
the granular layers of the epidermis, we hypothesized that lipid
vacuoles in the basal cells are not important in the pathogenesis
of ichthyosis in DCS with CGI-58 mutations. In all previous re-
ports, DCS patients showed ichthyosis, but the lipid vacuoles in
the basal epidermal layer were not always seen (Dorfman et al,
1974; Chanarin et al, 1975; Miranda et al, 1979; Elias andWilliams,
1985; Srebrnik et al, 1987; 1998; Venencie et al, 1988;Williams et al,
1988; Banuls et al, 1994; Kaassis et al, 1998;Wollenberg et al, 2000;
Pena-Penabad et al, 2001). Srebrnik et al (1998) suggested that large
lipid vacuoles were not correlated with DCS clinical severity. In
addition, a series of DCS patients with CGI-58 mutations
reported by Lefe' vre et al (2001) did not always show lipid
vacuoles in the basal cells, although patients with DCS always
showed ichthyosis. These facts also support the hypothesis that
large lipid vacuoles in the lower epidermis are not pathogenic.
Immuno£uorescent labeling for keratin 1, keratin 10, involu-
crin, and loricrin showed a normal distribution of keratiniza-
tion-associated structural molecules. These results together with
the ultrastructural ¢ndings clearly indicate that the corni¢ed cell
envelope and keratin network were not signi¢cantly disturbed in
the patient’s epidermis. The in situ TGase activity assay, however,
revealed an aberrant distribution pattern of TGase 1 activity
in the patient’s upper spinous and granular layers. It is known that
TGase 1 not only participates in the cross-linking of the corni¢ed
cell envelope structural proteins but also helps form the lipid
bound envelope by esteri¢cation of long-chain o-hydroxycera-
mides with corni¢ed cell envelope proteins (Nemes et al, 1999).
In X-linked ichthyosis, supraphysiologic levels of cholesterol sul-
fate in keratinocyte membranes distort the conformational mole-
cular structure of TGase 1 and inhibit TGase 1 activity (Nemes
et al, 2000). In this context, the abnormal distribution of TGase
1 activity in our patient may be caused by the accumulation of
abnormal lipid droplets and malformed lamellar granules close
to the cell membrane.
In conclusion, this study has revealed that a seriously truncated
CGI-58 protein leads to the defective formation of lamellar gran-
ules in human epidermis and that the CGI-58 protein is likely to
play an important role in the metabolism of lamellar granule
lipid contents.
We thank Ms Kaori Sakai, Ms Megumi Sato, and MsYuriko Okuno for their ¢ne
technical assistance on this project, Dr SayumiTsuzaki for consulting the patient, and
Dr Soo-Youl Kim for providing the anti-TGase 1 antibody.
REFERENCES
Akiyama M: The pathogenesis of severe congenital ichthyosis of the neonate. J Der-
matol Sci 21:96^104, 1999
Akiyama M, Kim D-K, Main DM, Otto CE, Holbrook KA: Characteristic mor-
phological abnormality of harlequin ichthyosis detected in amniotic £uid cells.
J Invest Dermatol 102:210^213, 1994
Akiyama M, Christiano AM,Yoneda K, Shimizu H: Abnormal corni¢ed cell envel-
ope formation in mutilating palmoplantar keratoderma unrelated to epidermal
di¡erentiation complex. J Invest Dermatol 111:133^138, 1998a
Akiyama M, Dale BA, Smith LT, Shimizu H, Holbrook KA: Regional di¡erence in
expression of characteristic abnormality of harlequin ichthyosis in a¡ected
fetuses. Prenat Diagn 18:425^436, 1998b
Akiyama M, Takizawa Y, Suzuki Y, Ishiko A, Matsuo I, Shimizu H: Compound
heterozygous TGM1 mutations including a novel missense mutation L204Q
in a mild form of lamellar ichthyosis. J Invest Dermatol 116:992^995, 2001
Akiyama M, Sawamura D, Shimizu H:The clinical spectrum of non-bullous conge-
nital ichthyosiform erythroderma and lamellar ichthyosis. Clin Exp Dermatol
28:235^240, 2003
CGI-58 AND LAMELLARGRANULES 1033VOL. 121, NO. 5 NOVEMBER 2003
Banuls J, Betlloch I, Botella R, Sevila A, Morell A, Roman P: Dorfman^Chanarin
syndrome (neutral lipid storage disease). A case report. Clin Exp Dermatol
19:434^437, 1994
Chanarin I, Patel A, Slavin G, Wills EJ, Andrews TM, Stewart G: Neutral-lipid
storage disease: A new disorder of lipid metabolism. Br Med J 1:553^555, 1975
Cygler M, Schrag JD, Sussman JL, Harel M, Silman I, Gentry MK, Doctor BP:
Relationship between sequence conservation and three-dimensional structure
in a large family of esterases, lipases, and related proteins. Protein Sci 2:366^382,
1993
Dale BA, Holbrook KA, Fleckman P, Kimball JR, Brumbaugh S, Sybert VP: Het-
erogeneity in harlequin ichthyosis, an inborn error of epidermal keratinization:
Variable morphology and structural protein expression and a defect in lamellar
granules. J Invest Dermatol 94:6^18, 1990
Dorfman ML, Hershko C, Eisenberg S, Sagher F: Ichthyosiform dermatosis with
systemic lipidosis. Arch Dermatol 110:261^266, 1974
Elias PM, Williams ML: Neutral lipid storage disease with ichthyosis. Defective
lamellar body contents and intracellular dispersion. Arch Dermatol 121:
1000^1008, 1985
Fartasch M,Williams ML, Elias PM: Altered lamellar body secretion and stratum
corneum membrane structure in Netherton syndrome: Di¡erentiation from
other infantile erythrodermas and pathogenic implications. Arch Dermatol
135:823^832, 1999
Gri⁄ths WAD, Judge MR, Leigh IM: Disorders of keratinization. In: Champion
RH, Burton JL, Burns DA, Breathnach SM, (eds).Textbook of Dermatology, 6th
edn. Oxford, London: Blackwell Science, 1998; p 1483^1588
Hashimoto K, Khan S: Harlequin fetus with abnormal lamellar granules and giant
mitochondria. J Cutan Pathol 19:247^252, 1992
Heikinheimo P, Goldman A, Je¡ries C, Ollis DL: Of barn owls and bankers: A lush
variety of a/b hydrolases. Struct Fold Des 7:R141^R146, 1999
Hilaire N, Ne' gre-Salvayre A, Salvayre R: Cellular uptake and catabolism of high-
density-lipoprotein triacylglycerol in human cultured ¢broblasts: Degradation
block in neural lipid storage disease. Biochem J 297:467^473, 1994
Hilaire N, Salvayre R, Thiers JC, BonnafeŁ MJ, Ne' gre-Salvayre A: The turnover of
cytoplasmic triacylglycerols in human ¢broblasts involves two separate acyl
chain length-dependent degradation pathways. J Biol Chem 270:27027^27034,
1995
Hohl D, Aeschlimann D, Huber M: In vitro and rapid in situ transglutaminase assays
for congenital ichthyoses ^ A comparative study. J Invest Dermatol 110:268^261,
1998
Igal RA, Coleman RA: Acylglycerol recycling from triacylglycerol to phospholipid,
not lipase activity, is defective in neutral lipid storage disease ¢broblasts. J Biol
Chem 271:16644^16651, 1996
Igal RA, Coleman RA: Neutral lipid storage disease: A genetic disorder with ab-
normalities in the regulation of phospholipid metabolism. J Lipid Res 39:31^
43, 1998
Kaassis C, Ginies JL, Berthelot J, Verret JL: Le syndrome de DorfmanChanarin.
Ann Dermatol Venereol 125:317^319, 1998
Kim I-G, McBride OW,Wang M, Kim SY, Idler WW, Steinert PM: Structure and
organization of the human transglutaminase 1 gene. J Biol Chem 267:7710^7717,
1992
Kim S-Y, Chung S-I, Yoneda K, Steinert PM: Expression of transglutaminase 1 in
human epidermis. J Invest Dermatol 104:211^217, 1995
Koone MD, RizzoWB, Elias PM,Williams ML, Lightner V, Pinnell SR: Ichthyosis,
mental retardation, and asymptomatic spasticity. A new neurocutaneous syn-
drome with normal fatty alcohol: NADþ oxidoreductase activity. Arch Der-
matol 126:1485^1490, 1990
Lai CH, Chou CY, Ch’ang LY, Liu CS, LinW: Identi¢cation of novel human genes
evolutionarily conserved in Caenorhabditis elegans by comparative proteomics.
Genome Res 10:703^713, 2000
Lefe' vre C, Jobard F, Caux F, et al: Mutations in CGI-58, the gene encoding a new
protein of the esterase/lipase/thioesterase subfamily, in Chanarin^Dorfman
syndrome. AmJ Hum Genet 69:1002^1012, 2001
Milner ME, O’GuinWM, Holbrook KA, Dale BA: Abnormal lamellar granules in
harlequin ichthyosis. J Invest Dermatol 99:824^829, 1992
Miranda A, DiMauro S, Eastwood A, et al: Lipid storage myopathy, ichthyosis, and
steatorrhea. Muscle Nerve 2:1^13, 1979
Nardini M, Dijkstra BW: a/b hydrolase fold enzymes: The family keeps growing.
Curr Opin Struct Biol 9:732^737, 1999
Nemes Z, Marekov LN, Fesus L, Steinert PM: A novel function for transglutaminase
1: Attachment of long-chain o-hydroxyceramides to involucrin by ester bond
formation. Proc Natl Acad Sci USA 96:8402^8407, 1999
Nemes Z, Demeny M, Marekov LN, Fesus L, Steinert PM: Cholesterol 3-sulfate
interferes with corni¢ed envelope assembly by diverting transglutaminase
1 activity from the formation of cross-links and esters to the hydrolysis of
glutamine. J Biol Chem 275:2636^2646, 2000
Ollis DL, Cheah E, Cygler M, et al: The a/b hydrolase fold. Protein Eng 5:197^211,
1992
Pena-Penabad C, Almagro M, Martinez W, et al: Dorfman^Chanarin syndrome
(neutral lipid storage disease): New clinical features. Br J Dermatol 144:430^432,
2001
PerryTB, Holbrook KA, Ho¡ MS, Hamilton EF, Senikas V, Fisher C: Prenatal diag-
nosis of congenital nonbullous ichthyosiform erythroderma (lamellar ichthyo-
sis). Prenat Diagn 7:145^155, 1987
Raghunath M, Hennies HC, Velten F, Wiebe V, Steinert PM, Reis A, Traupe H:
A novel in situ method for the detection of de¢cient transglutaminase activity
in the skin. Arch Dermatol Res 290:621^627, 1998
Rassner U, Feingold KR, Crumrine DA, Elias PM: Coordinate assembly of lipids
and enzyme proteins into epidermal lamellar bodies. Tissue Cell 31:489^498,
1999
Reynolds ES: The use of lead citrate at high pH as an electron-opaque stain in
electron microscopy. J Cell Biol 17:208^212, 1963
Richardson KC, Jarett L, Finke EH: Embedding in epoxy resins for ultrathin
sectioning in electron microscopy. StainTechnol 35:313^323, 1960
Schmuth M, Yosipovitch G, Williams ML, et al: Pathogenesis of the permeability
barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol 117:
837^847, 2001
Schrag JD, Cygler M: Lipases and a/b hydrolase fold. Meth Enzymol 284:85^107, 1997
Srebrnik A,Tur E, Perluk C, Elman M, Messer G, Ilie B, Krakowski A: Dorfman^
Chanarin syndrome: A case report and a review. J Am Acad Dermatol 17:
801^808, 1987
Srebrnik A, Brenner S, Ilie B, Messer G: Dorfman^Chanarin syndrome: Morpholo-
gic studies and presentation of new cases. AmJ Dermatopathol 20:79^85, 1998
Venencie PY, Armengaud D, Folde' s C,Vieillefond A, Coulombel L, Hadchouel M:
Ichthyosis and neutral lipid storage disease (Dorfman^Chanarin syndrome).
Pediatr Dermatol 5:173^177, 1988
Williams ML, Monger DJ, Rutherford SL, Hincenbergs M, Rehfeld SJ, Grunfeld C:
Neutral lipid storage disease with ichthyosis: Lipid content and metabolism of
¢broblasts. J Inherit Metab Dis 11:131^143, 1988
Williams ML, Coleman RA, Placezk D, Grunfeld C: Neutral lipid storage disease:
A possible functional defect in phospholipid-linked triacylglycerol meta-
bolism. Biochim Biophys Acta 1096:162^169, 1991
Williams MLK, Lynch PJ: Generalized disorders of corni¢cation: The ichthyoses. In:
Sams WM Jr, Lynch PJ, (eds). Principles and Practice of Dermatology, 2nd edn.
NewYork, NY: Churchill Livingstone, 1996; p 379^396
Wollenberg A, Geiger E, Schaller M, Wol¡ H: Dorfman^Chanarin syndrome in
a Turkish kindred: Conductor diagnosis requires analysis of multiple
eosinophils. Acta Dermato-Venereol 80:39^43, 2000
Zhang L, Godzik A, Skolnick J, Fetrow JS: Functional analysis of the Escherichia coli
genome for members of the a/b hydrolase family. Fold Des 3:535^548, 1998
1034 AKIYAMA ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
